As previous research on DNA methylation in lung NET lacked detailed clinical characterization, we wanted to assess the DNA methylation profiles of known prognostic subgroups, i.e., histologic subtype, metastatic disease, SSTR2 status, and endocrine activity. The gene discussed is SSTR2; the disease is metastatic neoplasm.